Gara Jalqabaatti › Kansa Endometiriyaalii › Virginia › Charlottesville
Qorannoo klinikaalii Kansa Endometiriyaalii Charlottesville, VA keessatti
Qorannoo 13 Kansa Endometiriyaalii f Charlottesville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Virginia Cancer Center, Charlottesville
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Virginia Cancer Center, Charlottesville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Virginia, Charlottesville
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Namoota walitti qabaa jiraSadarkaa 2
- University of Virginia Cancer Center, Charlottesville
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Namoota walitti qabaa jiraSadarkaa 2
- University of Virginia Cancer Center, Charlottesville
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Virginia, Charlottesville
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Charlottesville
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Virginia, Charlottesville
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 2
- University of Virginia Health System, Charlottesville
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Virginia Health System, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Virginia, Charlottesville
Vaginal Cuff Brachytherapy Fractionation Study
Namoota walitti qabaa jiraSadarkaa 3
- University of Virginia, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Charlottesville
Qorannoo Kansa Endometiriyaalii magaalota biroo keessatti
- Houston, TXQorannoo 68
- New York City, NYQorannoo 52
- Boston, MAQorannoo 50
- Arlington, VAQorannoo 39
- Nashville, TNQorannoo 38
- Los Angeles, CAQorannoo 34
- St. Louis, MOQorannoo 29
- Philadelphia, PAQorannoo 28
- San Antonio, TXQorannoo 27
- Columbus, OHQorannoo 25
- Oklahoma City, OKQorannoo 25
- Chicago, ILQorannoo 25
Qorannoo biroo Charlottesville keessatti
- Kansara Qara'a Non-Small CellQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 16
- Kansarii ProstateQorannoo 15
- Saree (Gosoota Hunda)Qorannoo 13
- Kansara MetastatikiiQorannoo 13
- Dhibee QaraQorannoo 13
- Cufama OnneeQorannoo 12
- Kansarii ColorectalQorannoo 10
- Kansarii OvariiQorannoo 10
- Diabetes Type 1Qorannoo 9
- Saree OljooQorannoo 9
- Kansarii PancreasQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.